What is the safety record of Monoclate-P®?
A. In more than 10 years of use and over 1 billion units dispensed, there have been no confirmed cases of viral transmissions with the use of Monoclate-P®. As with all plasma-derived products, the risk of transmission of infectious agents, including viruses, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.